Annual Revenue
N/A
December 31, 2023
Summary
- ONCT annual revenue is not available.
Performance
ONCT Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Revenue
N/A
September 30, 2024
Summary
- ONCT quarterly revenue is not available.
Performance
ONCT Quarterly Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
TTM Revenue
N/A
September 30, 2024
Summary
- ONCT TTM revenue is not available.
Performance
ONCT TTM Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
ONCT Revenue Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | - | - |
| 3 y3 years | - | - | - |
| 5 y5 years | - | - | - |
ONCT Revenue Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | ||||||
| 5 y | 5-year | ||||||
| alltime | all time |
Oncternal Therapeutics Revenue History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2011 | $8.07 M(-85.8%) | - | - |
| Jun 2011 | - | $1.65 M(-82.3%) | $10.21 M(+7.5%) |
| Mar 2011 | - | $9.29 M(-559.7%) | $9.50 M(-83.3%) |
| Dec 2010 | $56.79 M(+285.5%) | -$2.02 M(-256.0%) | $56.79 M(-9.1%) |
| Sep 2010 | - | $1.30 M(+38.6%) | $62.48 M(-3.6%) |
| Jun 2010 | - | $935.00 K(-98.3%) | $64.79 M(-4.3%) |
| Mar 2010 | - | $56.58 M(+1438.7%) | $67.68 M(+359.4%) |
| Dec 2009 | $14.73 M(+8.9%) | $3.68 M(+2.1%) | $14.73 M(+4.8%) |
| Sep 2009 | - | $3.60 M(-5.8%) | $14.05 M(+4.1%) |
| Jun 2009 | - | $3.82 M(+5.3%) | $13.50 M(+6.4%) |
| Mar 2009 | - | $3.63 M(+21.1%) | $12.69 M(-6.2%) |
| Dec 2008 | $13.53 M(+89.8%) | $3.00 M(-1.7%) | $13.53 M(+8.7%) |
| Sep 2008 | - | $3.05 M(+1.4%) | $12.45 M(+11.8%) |
| Jun 2008 | - | $3.01 M(-32.8%) | $11.13 M(+11.9%) |
| Mar 2008 | - | $4.47 M(+133.3%) | $9.94 M(+39.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2007 | $7.13 M(-5.0%) | $1.92 M(+10.7%) | $7.13 M(-27.4%) |
| Sep 2007 | - | $1.73 M(-5.0%) | $9.81 M(+7.2%) |
| Jun 2007 | - | $1.82 M(+10.2%) | $9.15 M(+15.1%) |
| Mar 2007 | - | $1.66 M(-64.0%) | $7.95 M(+5.9%) |
| Dec 2006 | $7.50 M(+98.4%) | $4.60 M(+329.1%) | $7.50 M(+111.3%) |
| Sep 2006 | - | $1.07 M(+72.1%) | $3.55 M(+14.5%) |
| Jun 2006 | - | $623.00 K(-48.5%) | $3.10 M(-28.0%) |
| Mar 2006 | - | $1.21 M(+87.3%) | $4.30 M(+13.8%) |
| Dec 2005 | $3.78 M(+102.6%) | $646.00 K(+3.9%) | $3.78 M(+8.7%) |
| Sep 2005 | - | $622.00 K(-66.0%) | $3.48 M(+7.6%) |
| Jun 2005 | - | $1.83 M(+165.9%) | $3.23 M(+29.3%) |
| Mar 2005 | - | $687.00 K(+99.7%) | $2.50 M(+34.0%) |
| Dec 2004 | $1.87 M | $344.00 K(-8.8%) | $1.87 M(+22.6%) |
| Sep 2004 | - | $377.00 K(-65.5%) | $1.52 M(+32.9%) |
| Jun 2004 | - | $1.09 M(+2003.8%) | $1.15 M(+2103.8%) |
| Mar 2004 | - | $52.00 K | $52.00 K |
FAQ
- What is the all time high annual revenue for Oncternal Therapeutics?
- What is the all time high quarterly revenue for Oncternal Therapeutics?
- What is the all time high TTM revenue for Oncternal Therapeutics?
What is the all time high annual revenue for Oncternal Therapeutics?
Oncternal Therapeutics all-time high annual revenue is $56.79 M
What is the all time high quarterly revenue for Oncternal Therapeutics?
Oncternal Therapeutics all-time high quarterly revenue is $56.58 M
What is the all time high TTM revenue for Oncternal Therapeutics?
Oncternal Therapeutics all-time high TTM revenue is $67.68 M